Competitive Tech Selected To Provide Pain Care Training To U.S.
Military Personnel
BORDER-BOTTOM:1pt; BORDER-LEFT:1pt; PADDING-LEFT:0.50em;
PADDING-RIGHT:0.50em; VERTICAL-ALIGN: BOTTOM; BORDER-TOP:1pt;
BORDER-RIGHT:1pt
BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; BORDER-COLLAPSE: collapse;
BORDER-TOP: 1pt; BORDER-RIGHT: 1pt
FAIRFIELD, Conn., Oct. 15, 2013 /PRNewswire/ --?In a pain care
skills training for military healthcare providers, technicians,
policy makers and program managers in Portsmouth, Virginia, Competitive
Technologies, Inc., (OTCQX: CTTC) (CTI) was selected as
one of the pain care training providers to our Nation's military
personnel. CTI's flagship 510-K cleared and CE-marked medical
device, Calmare? was highlighted as a promising pain
management device of choice.
(Logo:
http://photos.prnewswire.com/prnh/20131015/NY97852LOGO)
"This military venue afforded CTI a unique opportunity to
broaden Calmare's footprint within the military providers' and
policy makers' circles to demonstrate the benefits of using our
medical device," said CTI President & CEO Conrad Mir. "We strongly believe that the
Calmare biophysical approach provides a viable alternative to the
current standard of prescription drugs and opiates for patients
suffering from various types of pain."
Calmare Use in the U.S. Military
The U.S. military is
one of the largest providers of Calmare therapy in the world. The
Calmare device is offered and available at medical centers and
hospitals in all branches of service. Military providers use
Calmare to treat an assortment of chronic neuropathic pain
modalities including failed back surgery syndrome (FBSS), sciatic
and lumbar pain, phantom limb syndrome, pudendal pain,
post-herpetic neuralgia (PHN), post-surgical neuropathic pain,
brachial plexus neuropathy, lower back pain (LBP), complex regional
pain syndrome (CRPS or RSD), and cancer-related pain.
About the Company
Competitive Technologies Inc., (CTI)
is a biotechnology company developing and commercializing
innovative products and technologies. CTI is the licensed
distributor of the non-invasive Calmare? pain therapy
medical device, which incorporates the biophysical "Scrambler
Therapy"? technology developed to treat neuropathic and
cancer-derived pain by Professor Giuseppe
Marineo.
Forward-Looking Statements
Certain statements
contained in this press release are forward-looking statements that
involve risks and uncertainties. The statements contained herein
that are not purely historical are forward looking statements
within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. Forward-looking statements deal with the Company's current
plans, intentions, beliefs and expectations and statements of
future economic performance.? Forward-looking statements involve
known and unknown risks and uncertainties that may cause the
Company's actual results in future periods to differ materially
from what is currently anticipated. Factors that could cause or
contribute to such differences include those discussed from time to
time in reports filed by the Company with the Securities and
Exchange Commission. The Company cannot guarantee its future
results, levels of activity, performance or achievements.
Contacts:
|
|
Competitive
Technologies, Inc.
|
JV Public
Relations
|
Conrad
Mir
|
Janet
Vasquez
|
President and
CEO
|
Managing
Director
|
cmir@competitivetech.net
|
jvasquez@jvprny.com
|
973.798.8882
|
212.645.5498
|
?
The Calmare device is currently being
manufactured for sale by GEOMC Co., Ltd. of Seoul, South Korea.
Scrambler Therapy?:
www.scramblertherapy.org/english.htm
Calmare?: www.calmarett.com
www.competitivetech.net
SOURCE Competitive Technologies, Inc.